Traders Sell Shares of Monsanto (MON) on Strength (MON)

Traders sold shares of Monsanto (NYSE:MON) on strength during trading on Friday. $39.02 million flowed into the stock on the tick-up and $74.37 million flowed out of the stock on the tick-down, for a money net flow of $35.35 million out of the stock. Of all companies tracked, Monsanto had the 22nd highest net out-flow for the day. Monsanto traded up $0.51 for the day and closed at $116.78

A number of research analysts have recently commented on the company. Zacks Investment Research lowered Monsanto from a “buy” rating to a “hold” rating in a report on Monday, December 11th. Royal Bank of Canada reissued a “hold” rating and set a $128.00 price target on shares of Monsanto in a report on Wednesday, November 15th. Wells Fargo & Co raised their price target on Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a report on Tuesday, October 10th. Barclays reissued an “equal weight” rating and set a $124.00 price target (up from $120.00) on shares of Monsanto in a report on Thursday, October 5th. Finally, BMO Capital Markets reissued a “buy” rating and set a $128.00 price target on shares of Monsanto in a report on Thursday, October 5th. Twelve research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Monsanto has a consensus rating of “Hold” and an average target price of $124.61.

The company has a market cap of $51,291.58, a P/E ratio of 22.85, a price-to-earnings-growth ratio of 1.67 and a beta of 1.04. The company has a current ratio of 1.35, a quick ratio of 0.83 and a debt-to-equity ratio of 1.12.

Monsanto (NYSE:MON) last announced its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.41) by $0.61. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The business had revenue of $2.69 billion during the quarter, compared to analysts’ expectations of $2.51 billion. During the same quarter last year, the business posted $0.07 earnings per share. The company’s quarterly revenue was up 4.8% on a year-over-year basis. analysts predict that Monsanto will post 5.74 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, January 5th will be paid a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, January 4th. This represents a $2.16 annualized dividend and a yield of 1.85%. Monsanto’s dividend payout ratio is currently 42.27%.

In related news, CFO Pierre Courduroux sold 4,320 shares of the firm’s stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $122.00, for a total transaction of $527,040.00. Following the completion of the transaction, the chief financial officer now owns 48,388 shares of the company’s stock, valued at $5,903,336. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Steven Mizell sold 11,526 shares of the firm’s stock in a transaction dated Monday, October 9th. The shares were sold at an average price of $119.70, for a total value of $1,379,662.20. The disclosure for this sale can be found here. Insiders have sold 23,736 shares of company stock valued at $2,871,255 in the last ninety days. Company insiders own 0.79% of the company’s stock.

Hedge funds have recently made changes to their positions in the stock. Bruderman Asset Management LLC acquired a new position in shares of Monsanto in the 2nd quarter valued at $116,000. Tower Research Capital LLC TRC boosted its position in shares of Monsanto by 230.1% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock valued at $128,000 after purchasing an additional 750 shares during the period. Americafirst Capital Management LLC acquired a new position in shares of Monsanto in the 3rd quarter valued at $148,000. Penserra Capital Management LLC boosted its position in shares of Monsanto by 13.0% in the 2nd quarter. Penserra Capital Management LLC now owns 1,456 shares of the basic materials company’s stock valued at $172,000 after purchasing an additional 168 shares during the period. Finally, Fieldpoint Private Securities LLC boosted its position in shares of Monsanto by 100.6% in the 2nd quarter. Fieldpoint Private Securities LLC now owns 1,575 shares of the basic materials company’s stock valued at $186,000 after purchasing an additional 790 shares during the period. 75.45% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: This piece was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be read at https://www.com-unik.info/2017/12/29/traders-sell-shares-of-monsanto-mon-on-strength-mon.html.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

What are top analysts saying about Monsanto? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Monsanto and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit